H.R.6255 - To require mail-order pharmacies to notify customers when generic drugs become available and to prevent mail-order pharmacies from substituting drugs without the express authorization of the prescriber.111th Congress (2009-2010)
|Sponsor:||Rep. Shea-Porter, Carol [D-NH-1] (Introduced 09/29/2010)|
|Committees:||House - Energy and Commerce|
|Latest Action:||09/29/2010 Referred to the House Committee on Energy and Commerce.|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Subject — Policy Area:
- View subjects
Summary: H.R.6255 — 111th Congress (2009-2010)All Bill Information (Except Text)
Introduced in House (09/29/2010)
Requires a mail-order pharmacy to inform a customer to whom it dispenses a prescription brand name drug when a generic drug that is the pharmaceutical equivalent becomes available.
Permits a mail-order pharmacy to substitute a generic drug for a brand name drug or a brand name drug for a generic drug if the mail order pharmacy: (1) notifies the customer that the pharmacy will request that the prescriber provide an authorization to make such a substitution; and (2) after providing such notification, obtains the express written authorization of the prescriber of the drug to make such a substitution. Requires the prescriber to provide notice to the customer of an authorization.
Permits the Secretary of Health and Human Services (HHS) to assess civil penalties against a mail-order pharmacy for violations of this Act.
Declares that this Act preempts state laws to the extent any are inconsistent with this Act.